세계의 위풍선 시장 보고서 : 제품별, 충전 재료별, 임플란트 수술별, 용도별, 최종 사용자별, 지역별(2024-2032년)

The global intragastric balloons market size reached US$ 63.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 157.8 Million by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.

An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing weight. It is inserted through a non-surgical endoscopic procedure to confine the amount of food stored by the stomach, thereby providing an early feeling of satiety. It also aids in preserving the anatomy of the stomach and is bio-compatible while having negligible or no side-effects. As a result, the device is commonly used by individuals suffering from obesity and having a body mass index (BMI) ranging from 30 to 70.

The increasing prevalence of obesity is one of the key factors driving the growth of the market. Owing to sedentary lifestyles and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. This has consequently augmented the demand for various medically certified weight-loss procedures, including intragastric balloons. Furthermore, growing consumer preference for minimally invasive (MI) surgeries is also providing a boost to the market growth. Intragastric balloons serve as an effective non-surgical alternative for weight-loss as they are inserted orally and do not require any incisions on the body. Additionally, various technological advancements and product innovations are also creating a positive outlook for the market growth. Manufacturers are focusing on creating product variants with minimal side-effects, such as ulceration, gastric erosion and nausea, and are also designing balloons with adjustable gas/saline volumes. Other factors, including increasing health consciousness among consumers, and extensive research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intragastric balloons market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, filling material, implanting procedure, application and end-user.

Breakup by Product:

Single Intragastric Balloon

Double Intragastric Balloon

Triple Intragastric Balloon

Breakup by Filling Material:

Saline Filling

Gas Filling

Breakup by Implanting Procedure:

Surgical

Non-Surgical

Breakup by Application:

Obesity

Diabetes

Diet Control

Weight-Loss

Pre-Operative Weight Reduction

Others

Breakup by End-User:

Hospitals and Clinics

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Apollo Endosurgery, Obalon Therapeutics Inc., ReShape Medical Inc., Medicone, Medsil, Allurion Technologies Inc., Helioscopie, Spatz Fgia Inc., PlenSat, Districlass Medical SA, Endalis, Lexel SRL, Silimed Inc., Shandong Institute of Medical Instruments, etc.

Key Questions Answered in This Report:

• How has the global intragastric balloons market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global intragastric balloons market?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the filling material?
• What is the breakup of the market based on the implanting procedure?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global intragastric balloons market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Intragastric Balloons Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Single Intragastric Balloon
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Double Intragastric Balloon
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Triple Intragastric Balloon
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Filling Material

• 7.1 Saline Filling
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Gas Filling
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Implanting Procedure

• 8.1 Surgical
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Non-Surgical
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Application

• 9.1 Obesity
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Diabetes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Diet Control
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Weight-Loss
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Pre-Operative Weight Reduction
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast
• 9.6 Others
  • 9.6.1 Market Trends
  • 9.6.2 Market Forecast

10 Market Breakup by End-User

• 10.1 Hospitals and Clinics
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Ambulatory Surgical Centers
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Others
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 Apollo Endosurgery
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
    • 16.3.1.3 Financials
    • 16.3.1.4 SWOT Analysis
  • 16.3.2 Obalon Therapeutics Inc.
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 Financials
  • 16.3.3 ReShape Medical Inc.
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
  • 16.3.4 Medicone
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
  • 16.3.5 Medsil
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
  • 16.3.6 Allurion Technologies Inc.
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
  • 16.3.7 Helioscopie
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 Spatz Fgia Inc.
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 PlenSat
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
  • 16.3.10 Districlass Medical SA
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
  • 16.3.11 Endalis
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
    • 16.3.11.3 Financials
  • 16.3.12 Lexel SRL
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
    • 16.3.12.3 Financials
  • 16.3.13 Silimed Inc.
    • 16.3.13.1 Company Overview
    • 16.3.13.2 Product Portfolio
  • 16.3.14 Shandong Institute of Medical Instruments
    • 16.3.14.1 Company Overview
    • 16.3.14.2 Product Portfolio